The Antimicrobial Stewardship Clinical Care Standard aims to ensure that a patient with a bacterial infection receives optimal treatment with antibiotics. ‘Optimal treatment’ means the right antibiotic to treat their condition, the right dose, by the right route, at the right time and for the right duration based on accurate assessment and timely review.
The Antimicrobial Stewardship Clinical Care Standard provides advice to clinicians, consumers and health services on key components of care including:
The Commission undertook a public consultation on the draft Antimicrobial Stewardship Clinical Care Standard and related documentation from 18 December 2013 to 14 March 2014. Over seventy submissions were received from organisations and consumer groups. Meetings with key stakeholders and clinical networks also took place.
The Antimicrobial Stewardship Clinical Care Standard was supported by a topic working group comprised of consumers, clinicians, researchers and health organisations.
All members of the Antimicrobial Stewardship Clinical Care Standard Topic Working Group are required to disclose financial, personal and professional interests that could, or could be perceived to influence a decision made, or advice given to the Commission. Disclosures are updated prior to each meeting and managed in line with the Commission’s Policy on Disclosure of Interests.